Statistics

Total Visits

Views
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 566

Total Visits per Month

August 2016 September 2016 October 2016 November 2016 December 2016 January 2017 February 2017
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 2 3 4 1 0 3 0

File Downloads

Views
4403[1].pdf 210

Top Country Views

Views
United States 281
Russia 89
Poland 53
Denmark 26
Canada 22
China 22
United Kingdom 12
Germany 11
France 6
Hong Kong 3

Top City Views

Views
Minneapolis 120
Spartanburg 67
Houston 31
Miami Beach 16
Toronto 14
Zhengzhou 6
Beijing 5
San Jose 5
Brighton 4
Ottawa 4